Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Erik Wist, MD, PhD
Woman Max 99 years
Erik Wist, MD, PhD
Update Il y a 4 ans
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC
We want to compare Taxol given weekly with Taxotere given every 3 week both in comination with Xeloda. We are going to compare time to treatment failure and quality of life.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Erik Wist, MD, PhD
Update Il y a 4 ans
Effect of SBG in Patients With Breast Cancer
This study is set up to determine whether soluble beta-glucan (SBG) has - unfavourable side effects - beneficial treatment effects when given in combination with standard antibody ...
Country
None
organs
None
Specialty
None
Closed trial
More information